Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Cipla
Queensland Health
Moodys
Express Scripts
McKesson

Generated: August 24, 2019

DrugPatentWatch Database Preview

Patent: 8,637,655

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,637,655
Title:Amelogenin SNP on chromosome X
Abstract: Disclosed are methods for gender determination in the intron 1 region of the amelogenin locus and a newly discovered single nucleotide polymorphism (SNP) within the X chromosome of the amelogenin locus which can cause allelic dropout. Also disclosed are kits useful in gender determination.
Inventor(s): Mulero; Julio (Sunnyvale, CA), Green; Robert (Cupertino, CA), Lagace; Robert (Oakland, CA), Hennessy; Lori (San Mateo, CA)
Assignee: Life Technologies Corporation (Carlsbad, CA)
Application Number:12/856,530
Patent Claims:see list of patent claims

Details for Patent 8,637,655

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ➤ Sign Up Life Technologies Corporation (Carlsbad, CA) 2037-11-06 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ➤ Sign Up Life Technologies Corporation (Carlsbad, CA) 2037-11-06 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Sign Up Life Technologies Corporation (Carlsbad, CA) 2037-11-06 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 8,637,655

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 2011020075 Apr 14, 2011
World Intellectual Property Organization (WIPO) 2011020075 Feb 17, 2011
United States of America 2011237443 Sep 29, 2011
European Patent Office 2464754 Jun 20, 2012
European Patent Office 2464754 Mar 12, 2014
European Patent Office 2464754 Nov 14, 2012
>Country >Patent Number >Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Accenture
UBS
US Army
Cipla
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.